RATIONALE: Several studies have demonstrated that type-1 interferons (T1-IFN)s suppress Th2-type (T2) inflammation in vitro. Both pathways play important roles in asthma pathogenesis; however, their relationship in vivo is unknown. We investigated upper airway gene expression in children with asthma during disease stability, upper respiratory infections (URI)s, and asthma exacerbations to define the relationship between these pathways. METHODS: 165 children with exacerbation-prone asthma in the Inner City Asthma Consortium MUPPITS1 cohort had nasal lavage sampling at baseline and during a one-week period following onset of URI symptoms with or without resultant asthma exacerbations. Gene expression was assessed by RNA-sequencing and modular analysis of T1-IFN (including STAT1, STAT2, IRF7) and T2 (including IL4, IL5, IL13) response gene modules, and virus infection by quantitative PCR. RESULTS: There was a significant non-linear association between T1-IFN and T2 response gene expression modules (quadratic model: p<1E-10, r 2 50.23), which demonstrated an inverse association between the pathways at moderate T1-IFN expression levels, but a positive association at high levels. The positive association was seen predominantly in rhinovirus-positive URIs and asthma exacerbations. Furthermore, rhinovirus load was significantly correlated with T1-IFN module expression (p51.25E-9, R50.47). CONCLUSIONS: In children with asthma, at high levels of T1-IFN response, T1-IFN gene expression was unexpectedly positively associated with T2 gene expression. This was most pronounced in children with rhinovirus infections. The results suggest that while negative feedback may normally exist between the two pathways, there can be an uncoupling of this negative feedback in the airway of children with asthma during respiratory illnesses. There is a strong genetic component to the development of allergies; however, few mutations predisposing to atopic sensitization are known. We performed a forward genetic screen to discover genes essential for regulating atopic sensitization. METHODS: We measured the antigen-specific IgE antibody responses to a model cysteine protease allergen, papain, injected intraperitoneally into N-ethyl-N-nitrosourea (ENU) mutagenized mice. G1 founder males with random, ENU-induced single base pair mutations were bred to wild-type females, and subsequently to their daughters (G2) to produce homozygous mutations in G3 mice, which were screened for papain-specific IgE responses after a single intraperitoneal injection. Papain-specific IgE was compared to all G3 genotypes to map linked genes in dominant, semidominant, or recessive inheritance patterns. RESULTS: 16,115 G3 mice in 702 pedigreeswere screened. These mice incorporated a total of 38,585 non-synonymous mutations affecting 14,634 genes and saturation was assessed at 14.3% with > _ one homozygote examined for IgE response to papain. Mutations in two immune pathways altered allergen-specific IgE: class switch recombination (Itch, Itk, Jak3, Stat6, and Map3k8) and B cell receptor signaling (Ighe, Blk, Syk, Plcg2, Rasgrp3, Cd19, and Pik3r1). Increased papain-specific IgE was confirmed for each B cell receptor signaling mutation and demonstrated a dominant or semi-dominant inheritance pattern without significant immunodeficiency. CONCLUSIONS: From finding 7 disclosed and 2 undisclosed dominant phenotypes, we estimate many genes regulate atopic sensitization, which may account for the very high frequency of the atopic phenotype in the general population. + , and LAP + Tregs by EPIT was not observed in the absence of Langerhans cells. CONCLUSIONS: The preferential expression of integrin avb8 by LCs and their essential role in Tregs induction strongly suggest a role of the TFG-b pathway in the mechanism of induction of tolerance by EPIT.
